Precision Medicine: Targeting Cancer at Its Source By MedPark Hospital

Cancer changes lives in an instant—often leaving patients facing uncertainty, difficult decisions, and the fear of choosing the wrong treatment. Today, however, a new approach is transforming that journey. Precision medicine uses each patient’s unique genetic blueprint to guide therapy, replacing trial and error with clarity, confidence, and a far greater chance of success.

At MedPark Hospital, this approach is led by Dr. Sudpreeda Chainitikun (Dr. Dai), a medical

oncologist dedicated to turning complex science into meaningful outcomes for patients. By

identifying the exact mutations driving a cancer, treatments can be carefully selected to stop the disease at its source—offering not just effectiveness, but reassurance in every step forward.

With Next Generation Sequencing (NGS), hundreds of genes can be analyzed within days,

revealing critical insights that might otherwise remain hidden. Combined with MedPark’s in-house genomic laboratory, this allows patients to access the most appropriate targeted therapies faster—sometimes when time matters most.

For many patients, this means no longer asking, “What if this doesn’t work?”—but finally

feeling, “This is the treatment meant for me.”

Precision medicine is more than innovation—it is a shift toward truly personalized care, where patients regain control, avoid unnecessary suffering, and move forward with confidence and hope.

Read more: https://medpark.hospital/CCTnews

Book appointment: https://medpark.hospital/ApptP2

✉️ Email: expatservice@medparkhospital.com

☎️ Phone: +66 2 023 3333